Betekenis van:
microorganism

Voorbeeldzinnen

1. Microorganism
2. The active substance shall consist of nucleic acid sequence(s) or genetically modified microorganism(s) or virus(es).
3. New data were submitted in support of the application for authorisation without a time limit of that microorganism.
4. Citrobacter/Soy Protein Ferment is the product obtained by fermentation of soy protein by the microorganism Citrobacter
5. Gene therapy medicinal product containing recombinant nucleic acid sequence(s) or genetically modified microorganism(s) or virus(es)
6. Acidophilus/Vitis vinifera Ferment is the product obtained by fermentation of grapes (Vitis vinifera) by the microorganism Acidophilus
7. Accordingly, the use of that microorganism for calves and piglets, as specified in the Annex, should be authorised without a time limit.
8. Candida/Garcinia Cambogia Ferment is the product obtained by the fermentation of an extract of Garcinia cambogia by the microorganism Candida
9. for products containing a microorganism or a virus, data on the genetic modification, sequence analysis, attenuation of virulence, tropism for specific tissues and cell types, cell cycle dependence of the microorganism or virus, pathogenicity and characteristics of the parental strain shall be provided;
10. The use of the microorganism preparation of Enterococcus faecium (NCIMB 11181) was provisionally authorised, for the first time, for calves and piglets by Commission Regulation (EC) No 2690/1999 [2].
11. Lactobacillus/Glycerin/Hydrolyzed Casein/Lactose/Catharanthus Roseus Seed/Faex Extract Ferment is the product obtained from the fermentation of of glycerin, hydrolyzed casein, lactose, crushed periwinkle (Catharanthus roseus, Apocynaceae) and yeast extract by the microorganism Lactobacillus
12. Candida bombicola/Sucrose/Vegetable Acid Ester Ferment is the product obtained by the fermentation of sucrose and methyl, ethyl and glyceryl esters of rapeseed oil, sunflower seed oil and palm acids by the microorganism Candida bombicola
13. The application concerns authorisation of a new use of the microorganism preparation Bacillus cereus var. toyoi NCIMB 40112/CNCM I-1012 (Toyocerin) for turkeys for fattening, to be classified in the additive category ‘zootechnical additives’.
14. The finished medicinal product shall consist of nucleic acid sequence(s) or genetically modified microorganism(s) or virus(es) formulated in their final immediate container for the intended medical use.
15. The application concerns the authorisation of a new use of the microorganism preparation Bacillus cereus var. toyoi NCIMB 40112/CNCM I-1012 as a feed additive for rabbit breeding does, to be classified in the additive category ‘zootechnical additives’.